CalbaTech, which acquires and incubates early-stage life science companies, said this week that it has bought oligo and reagent provider Molecula Research Laboratories.

Financial terms of the deal were not disclosed.

Begun as an antisense oligo vendor, Molecula now offers a variety of RNAi products including custom siRNAs and siRNA transfection reagents, and plans to begin selling siRNA libraries.

Molecula CEO Matt Maupin, said CalbaTech, will remain in his current position with the company.